A phase 1/2, open-label study of repotrectinib in pediatric and young adult patients with advanced or metastatic malignancies harboring ALK, ROS1, or NTRK1-3 alterations Meeting Abstract
| Authors: | Dubois, S.; O'Donohue, T.; Kang, H. J.; Federman, N.; Watt, T.; Cluster, A.; Zimmerman, Z.; Trone, D.; Mascarenhas, L. |
| Abstract Title: | A phase 1/2, open-label study of repotrectinib in pediatric and young adult patients with advanced or metastatic malignancies harboring ALK, ROS1, or NTRK1-3 alterations |
| Meeting Title: | 53rd Congress of the International Society of Paediatric Oncology (SIOP) |
| Journal Title: | Pediatric Blood and Cancer |
| Volume: | 68 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Oct 21-24 |
| Meeting Location: | Virtual |
| ISSN: | 1545-5009 |
| Publisher: | Wiley Periodicals, Inc |
| Date Published: | 2021-11-01 |
| Start Page: | S54 |
| End Page: | S55 |
| Language: | English |
| ACCESSION: | WOS:000708132100113 |
| PROVIDER: | wos |
| PUBMED: | 34662504 |
| DOI: | 10.1002/pbc.29349 |
| Notes: | Meeting Abstract: O0113 / #574 -- Source: Wos |
